Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for IQVIA Holdings (IQV) through the VizualStocks API.
Revenue from IQVIA healthcare data, analytics, technology, consulting and commercialization services for life-sciences customers. The current segment includes former Contract Sales and Medical Solutions and excludes Real-World offerings transferred to R&D in January2026.
commercialSolutionsRevenueIQVIA R&D Solutions quarterly net new bookings divided by corresponding quarterly revenue, as directly reported by the issuer. This quarter ratio is separate from the trailing-twelve-month book-to-bill measure.
rDBookToBillIQVIA R&D Solutions contracted backlog at period end, representing future revenue expected from signed research-service awards. Contracts can be cancelled or delayed, so backlog is distinct from recognized revenue and the expected next-twelve-month conversion amount.
rDContractedBacklogIQVIA R&D Solutions net new service bookings during the quarter, after cancellations and including the reported reimbursed-expense component. This is new business awarded in the period, distinct from the period-end contracted backlog.
rDNetNewBookingsRevenue from IQVIA clinical-development services and related research solutions, including reimbursed expenses. The January2026 segment incorporates transferred Real-World Late Phase and related clinical offerings, with explicit recast history.
rDSolutionsRevenue